Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis

ClinicalTrials.gov ID: NCT02842021

Public ClinicalTrials.gov record NCT02842021. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Active- and Vehicle-Controlled Study to Compare the Efficacy and Safety of Products S2G6T-1, S2G6T-2, S2G6T-3 and S2G6T-4 in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis

Study identification

NCT ID
NCT02842021
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sol-Gel Technologies, Ltd.
Industry
Enrollment
283 participants

Conditions and interventions

Conditions

Interventions

  • S2G6T-1 Drug
  • S2G6T-2 Drug
  • S2G6T-3 Drug
  • S2G6T-4 Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2016
Primary completion
Sep 30, 2017
Completion
Sep 30, 2017
Last update posted
Nov 17, 2020

2016 – 2017

United States locations

U.S. sites
19
U.S. states
10
U.S. cities
18
Facility City State ZIP Site status
TCR Medical Corporation San Diego California 92123
University Clinical Trials, Inc. San Diego California 92123
Tampa Bay Medical Research Clearwater Florida 33761
Tory Sullivan, MD, PA North Miami Beach Florida 33162
Park Avenue Dermatology Orange Park Florida 32073
Mid Atlantic Research for Health Baltimore Maryland 21214
Minnesota Clinical Study Center Fridley Minnesota 55432
Academic Dermatology Associates Albuquerque New Mexico 87106
Skin Search of Rochester, Inc. Rochester New York 146232
Tennessee Clinical Research Center Nashville Tennessee 37215
DermResearch, Inc. Austin Texas 78759
J&S Studies, Inc College Station Texas 77845
Suzanne Bruce & Associates, PA / The Center for Skin Research Houston Texas 77056
Suzanne Bruce & Associates ,PA / The Center for Skin Research Katy Texas 77494
DermResearch New Braunfels New Braunfels Texas 78130
Endeavor Clinical Trials, PA San Antonio Texas 78229
Dermatology Research Center, Inc. Salt Lake City Utah 84117
The Education & Research Foundation Inc. Lynchburg Virginia 24501
Virginia Clinical Research Inc. Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02842021, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 17, 2020 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02842021 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →